Paraneoplastic Syndromes (Lecture 2)

Slide 1 · Paraneoplastic syndromes

Systemic manifestations of pulmonary neoplasms

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define paraneoplastic syndromes and separate them from local tumor effects or metastasis.

Link characteristic ectopic products and immune responses to their clinical syndromes.

Recognize subtype tendencies: Small cell carcinoma versus squamous cell carcinoma.

Explain why a systemic syndrome may precede discovery of a pulmonary tumor.

Slide 3 · What makes a syndrome paraneoplastic?

Symptoms are not explained by the physical location of the primary or metastatic tumor.

They are not simply the expected function of the normal tissue of tumor origin.

They arise from ectopic mediators or cancer-associated systemic host responses.

The syndrome may be the first clinically detectable sign of an occult cancer.

Slide 4 · Three pathways to systemic symptoms

Local tumor or invasion

Airway obstruction, collapse or infection

Superior vena cava compression

Neural invasion in a Pancoast tumor

Paraneoplastic pathway

Ectopic ACTH, ADH or PTH-related protein

Autoimmune neuromuscular dysfunction

Clotting or connective-tissue changes

Anatomic invasion ≠ distant paraneoplastic effect.

Slide 5 · Why recognition matters

Systemic findings can appear before a lung lesion is clinically apparent.

Endocrine, neurologic, and vascular complications may be clinically significant or lethal.

Some findings imitate metastatic spread and can distort staging assumptions.

An unexplained compatible syndrome should prompt evaluation for an underlying malignancy.

Slide 6 · Two broad mechanistic routes

Pulmonary neoplasm

Cellular products or tumor antigens

Humoral secretion

Hormone / peptide / cytokine signal

Immune or host response

Autoimmunity / coagulation / tissue change

Schematic

Different syndromes have distinct causal mechanisms; The routes are not interchangeable.

Slide 7 · Lung cancer: Relevant histologic context

The major carcinomas are adenocarcinoma, squamous cell carcinoma, and small cell carcinoma.

Small cell carcinoma shows neuroendocrine differentiation and can secrete ectopic peptides.

Squamous cell carcinoma is a classic setting for PTH-related protein–associated hypercalcemia.

Any histologic subtype can occasionally produce any one of the described hormones.

Slide 8 · Histology predicts tendencies—not certainty

Tumor category

Typical association

Important qualifier

Small cell carcinoma

ACTH and ADH secretion

Predominant, not exclusive

Squamous cell carcinoma

Hypercalcemia

Often linked to PTH-related protein

Other lung carcinomas

Variable paraneoplastic findings

No subtype absolutely excluded

Slide 9 · How frequent are endocrine paraneoplastic effects?

Clinically significant syndromes related to the listed humoral mediators occur in approximately 1%–10% of lung cancer patients.

This range describes the specified endocrine or hormone-like factors in the lung chapter.

It should not be confused with the broader estimate of all paraneoplastic syndromes across cancers.

An uncommon syndrome may nevertheless be the dominant presenting problem.

Slide 10 · The endocrine repertoire of lung tumors

Tumor-derived mediator

Recognized manifestation

Antidiuretic hormone (ADH)

Syndrome of inappropriate ADH secretion

Adrenocorticotropic hormone (ACTH)

Cushing syndrome

PTH-related protein and other factors

Hypercalcemia

Calcitonin / gonadotropins

Hypocalcemia / gynecomastia

Serotonin and bradykinin

Carcinoid syndrome

Slide 11 · ADH-mediated paraneoplastic hyponatremia

Lung tumor

Ectopic antidiuretic activity

Kidney

Water retention despite inappropriate context

Circulation

Dilutional hyponatremia (SIADH)

Schematic

Slide 12 · SIADH: The causal distinction

The tumor-associated problem is inappropriate antidiuretic activity—not compression of the kidney.

Retained water lowers the concentration of sodium in extracellular fluid.

This is a systemic endocrine effect even when the thoracic lesion is small.

Robbins especially associates ectopic ADH production with small cell carcinoma.

Slide 13 · Case: Unexplained hyponatremia

Vignette

An individual is found to have persistent hyponatremia. Further evaluation reveals a pulmonary mass that proves to be small cell carcinoma.

Interpretation

Recognize a systemic endocrine effect.

Identify the likely ectopic mediator.

Answer

The textbook association is ectopic ADH secretion causing SIADH; Direct tumor spread is not needed.

Illustrative teaching scenario — not a clinical case report

Slide 14 · ACTH-mediated ectopic Cushing syndrome

Pulmonary tumor

Ectopic ACTH / ACTH-like peptides

Adrenal cortex

Excess glucocorticoid stimulation

Patient

Cushing syndrome

Schematic

Slide 15 · Why small cell carcinoma is prominent

Ectopic ACTH production is predominantly associated with small cell carcinoma among lung cancers.

The tumor can release ACTH or ACTH-like products without an endocrine tissue of origin.

Clinical hypercortisolism can therefore signal an underlying lung malignancy.

The relationship is characteristic but not absolute.

Slide 16 · POMC processing and ectopic corticotropin

Pro-opiomelanocortin

Large ACTH precursor (POMC)

Tumor peptide production

POMC and corticotropin can circulate

Clinical effect

Ectopic ACTH-dependent Cushing syndrome

Schematic

Slide 17 · Ectopic versus pituitary ACTH secretion

Ectopic ACTH in lung cancer

Produced outside native pituitary tissue

POMC and corticotropin may both be elevated

Paraneoplastic interpretation

Pituitary ACTH excess

ACTH from pituitary cells

Source notes circulating POMC distinction

Not a paraneoplastic syndrome

POMC as a distinguishing biologic observation, not a standalone clinical test algorithm.

Slide 18 · Case: Cushing syndrome before a lung diagnosis

Vignette

A patient develops Cushing syndrome; Imaging subsequently identifies a small cell pulmonary carcinoma.

Interpretation

Ectopic secretion explains the endocrine phenotype.

The syndrome may precede recognition of the pulmonary lesion.

Answer

ACTH or an ACTH-like peptide is the textbook-supported mechanism.

Illustrative teaching scenario — not a clinical case report

Slide 19 · Hypercalcemia: Two distinct cancer mechanisms

Bone destruction can release calcium when tumors involve the skeleton.

Extraosseous tumors can also produce circulating calcemic substances.

Only the second mechanism is paraneoplastic humoral hypercalcemia.

Distinguishing mechanisms prevents incorrect attribution of hypercalcemia to osseous metastasis.

Slide 20 · Humoral hypercalcemia versus osteolysis

Humoral paraneoplastic

Extraosseous tumor releases calcemic factor

PTH-related protein is a leading mediator

Does not require skeletal metastases

Osteolytic cancer-associated

Primary bone tumor or bone metastasis causes resorption

Calcium liberated locally from bone

Not classified as paraneoplastic here

Slide 21 · PTH-related protein raises serum calcium

Squamous cell carcinoma

PTH-related protein secretion

Bone and kidney

Bone resorption + renal Ca retention

Blood

Hypercalcemia

Schematic

Slide 22 · PTH-related protein and PTH: Shared receptor

PTH-related protein has partial structural homology with parathyroid hormone.

Both interact with the PTH/PTH-related protein G-protein–coupled receptor.

PTH-related protein promotes skeletal calcium mobilization and renal calcium conservation.

It also diminishes renal phosphate transport, contributing to its biochemical phenotype.

Slide 23 · Why squamous carcinoma is a classic association

The most common lung tumor linked to hypercalcemia is squamous cell carcinoma.

Its associated humoral mechanism is commonly PTH-related protein secretion.

PTH-related protein is also produced in small amounts by normal epithelial tissues.

Association with squamous differentiation does not make the finding histologically diagnostic.

Slide 24 · Other mediators in malignancy-associated hypercalcemia

Mediator in Robbins

Mechanistic grouping

PTH-related protein

Humoral calcemic factor

Interleukin-1 and tumor necrosis factor

Inflammatory cytokines

Transforming growth factor-α

Growth-factor pathway

Prostaglandin E and vitamin D metabolites

Other implicated humoral pathways

Not every mediator has the same evidentiary strength in every tumor.

Slide 25 · Interpreting hypercalcemia in a lung cancer patient

First consider whether skeletal lesions could explain an osteolytic mechanism.

If a humoral effect is implicated, PTH-related protein is the textbook’s principal candidate.

Tumor histology shifts suspicion toward squamous carcinoma but is not definitive.

A systemic metabolic abnormality alone cannot establish tumor subtype or disease stage.

Slide 26 · Case: Hypercalcemia without bone metastases

Vignette

A lung squamous cell carcinoma is accompanied by hypercalcemia; No osseous metastatic explanation is evident.

Interpretation

Select the paraneoplastic humoral pathway.

Explain the biologic consequence for bone and renal handling.

Answer

PTH-related protein acting on the PTH/PTHrP receptor is the leading mechanism.

Illustrative teaching scenario — not a clinical case report

Slide 27 · Calcitonin: A less familiar endocrine association

Calcitonin is listed among hormone-like substances elaborated by lung cancers.

The lung chapter links tumor-associated calcitonin production with hypocalcemia.

This is distinct from the common hypercalcemia pathway of PTH-related protein.

The source does not provide a frequency or subtype-specific rule for this effect.

Slide 28 · Ectopic gonadotropins and gynecomastia

Gonadotropin production is included among paraneoplastic activities of lung tumors.

The recognized endocrine manifestation is gynecomastia.

The mechanism differs from ADH-related sodium changes and PTH-related calcium changes.

Its presence does not identify a unique lung carcinoma histotype.

Slide 29 · Vasoactive mediators and carcinoid syndrome

Functioning pulmonary tumor

Serotonin and bradykinin

Systemic vasoactive actions

Episodic physiological effects

Patient

Flushing, diarrhea, cyanosis

Schematic

Slide 30 · Pulmonary carcinoid syndrome

Functioning bronchial carcinoid tumors may produce vasoactive amines.

Intermittent diarrhea, flushing, and cyanosis.

Approximately 10% of bronchial carcinoids develop the classic syndrome.

Most pulmonary carcinoids do not show this secretory activity.

Slide 31 · Pulmonary carcinoid and small cell carcinoma

Carcinoid tumor

Neuroendocrine lung neoplasm with often indolent behavior

Secretion may lead to carcinoid syndrome

Typical and atypical forms

Small cell carcinoma

High-grade, aggressive neuroendocrine carcinoma

Ectopic ADH and ACTH especially associated

Usually widely disseminated when recognized

Slide 32 · Endocrine synthesis by mediator

Syndrome

Mediator

Lung association

SIADH

ADH

Small cell predominant

Cushing syndrome

ACTH

Small cell predominant

Hypercalcemia

PTH-related protein

Squamous predominant

Carcinoid syndrome

Serotonin / bradykinin

Functional bronchial carcinoid

Slide 33 · Immune-mediated neurologic syndromes

Systemic neuromuscular manifestations may occur without neural invasion.

Examples include Lambert–Eaton myasthenic syndrome and sensory neuropathy.

The broader paraneoplastic spectrum includes encephalitis and cerebellar degeneration.

The mechanisms frequently involve immunologic cross-reaction against host neural structures.

Slide 34 · A model for onconeural autoimmunity

Tumor antigens

Neural-associated antigens expressed in cancer

Host immunity

T-cell responses or cross-reactive antibodies

Neural injury

Functional deficit beyond tumor site

Schematic

This as a proposed mechanism; Not all syndromes are fully understood.

Slide 35 · Lambert–Eaton: The target is presynaptic

Antibodies inhibit a presynaptic calcium channel at the neuromuscular junction.

Reduced calcium-dependent acetylcholine release impairs transmission.

The clinical result is weakness, particularly involving the extremities.

This is an antibody-associated paraneoplastic mechanism—not direct muscle metastasis.

Slide 36 · Neuromuscular transmission in Lambert–Eaton

Presynaptic calcium channel

Antibody-mediated inhibition

Motor nerve terminal

Reduced acetylcholine release

Muscle endplate

Weaker neuromuscular response

Schematic

Slide 37 · Facilitation with repeated activity

Lambert–Eaton differs from classical myasthenia gravis in its response to repetitive activity.

A brief interval of muscle use can augment strength.

Rapid repetitive stimulation increases the muscle response.

These features support a presynaptic transmission defect.

Slide 38 · Lambert–Eaton versus myasthenia gravis

Lambert–Eaton

Presynaptic calcium-channel antibodies

Extremity weakness typical

Response increases after brief activity

Myasthenia gravis

Postsynaptic ACh receptor / related targets

Ocular symptoms frequently prominent

Weakness typically worsens with exertion

Slide 39 · Why a neuromuscular syndrome may precede cancer

Approximately half of Lambert–Eaton patients have an underlying malignancy.

The associated cancer is most often small cell carcinoma of the lung.

Neurologic symptoms sometimes appear years before cancer detection.

The textbook proposes tumor expression of the relevant calcium channel as an autoimmune trigger.

Slide 40 · Case: Weakness improves after muscle use

Vignette

A patient has limb weakness that transiently improves after brief repetitive contractions; A pulmonary neoplasm is subsequently found.

Interpretation

Identify the neuromuscular-junction level.

Name the expected autoantibody target.

Answer

Lambert–Eaton: A presynaptic calcium channel, with small cell carcinoma as an important cancer association.

Illustrative teaching scenario — not a clinical case report

Slide 41 · Sensory neuropathy as a paraneoplastic clue

Lung carcinoma may be accompanied by a peripheral neuropathy.

The lung chapter emphasizes a predominantly sensory presentation.

The broader neoplasia chapter considers immune-mediated nerve injury among possible mechanisms.

Clinical localization is distinct from tumor compression of a nerve.

Slide 42 · Central neurologic paraneoplastic patterns

The broader textbook discussion lists encephalitis and cortical cerebellar degeneration.

These syndromes may reflect an aberrant anti-tumor response cross-reacting with neural antigens.

T-cell injury is implicated; Neuronal cross-reactive antibodies are found in some cases.

The text emphasizes incomplete understanding of their causes.

Slide 43 · Neural invasion versus paraneoplastic neurologic disease

Direct tumor effect

Apical tumor invades local sympathetic structures

Pancoast-associated Horner syndrome

Anatomic localization is explanatory

Remote immune effect

Lambert–Eaton or sensory neuropathy

No direct neural invasion required

Immune-mediated dysfunction is implicated

Slide 44 · Cutaneous paraneoplastic patterns

Acanthosis nigricans is among the dermatologic changes associated with lung cancer.

The neoplasia chapter also describes cancer-associated dermatomyositis.

Skin findings can appear before recognition of the primary neoplasm.

Neither skin disorder is specific to lung cancer.

Slide 45 · Acanthosis nigricans: Recognizable morphology

Gray-black, thickened patches of skin with a velvety surface are characteristic.

Stomach, lung and uterine carcinomas among associated cancers.

The proposed pathways include immune signals and epidermal growth-factor activity.

Abrupt onset in an appropriate clinical context can prompt malignancy assessment.

Slide 46 · Dermatomyositis in the paraneoplastic spectrum

The generalized paraneoplastic classification includes dermatomyositis.

Bronchogenic and breast carcinomas are listed associations.

The proposed mechanism is immunologic rather than local skin invasion.

Its presence is a malignancy clue, not a reliable indicator of lung tumor subtype.

Slide 47 · Cutaneous clues: Avoid overinterpretation

Acanthosis nigricans can occur in non-neoplastic conditions as well.

That a subset of cases are cancer-associated.

Clinical context and temporal onset influence the significance of the finding.

A paraneoplastic label should not be assigned solely from skin morphology.

Slide 48 · Hypertrophic pulmonary osteoarthropathy

Pulmonary malignancy

Associated systemic connective-tissue disorder

Skeletal changes

Periosteal new bone + joint involvement

Clinical signs

Painful arthropathy and digital clubbing

Schematic

Slide 49 · Three components of hypertrophic osteoarthropathy

Periosteal new bone forms preferentially along distal long bones and bones of hands and feet.

Adjacent joints show arthritis.

Clubbing of fingers or other digits accompanies the syndrome.

The complete constellation is more informative than clubbing alone.

Slide 50 · Where does periosteal bone form?

Distal portions of long bones.

Metatarsals and metacarpals are named sites.

Proximal phalanges may also develop new periosteal bone.

These osseous changes distinguish osteoarthropathy from an isolated nail change.

Slide 51 · Digital clubbing is not identical to osteoarthropathy

Isolated clubbing

Change in distal digit contour

Occurs in multiple non-neoplastic disorders

Does not prove periostitis or cancer

Hypertrophic osteoarthropathy

Clubbing PLUS periosteal new bone

Arthritis of adjacent joints

Distinct paraneoplastic clinical complex

Slide 52 · Clubbing has nonmalignant causes

Diffuse pulmonary diseases may produce finger clubbing.

Additional associations include congenital cyanotic heart disease and liver disease.

Inflammatory bowel disease is another listed context.

Thus, a clubbed digit is not pathognomonic for lung carcinoma.

Slide 53 · Mechanism of hypertrophic osteoarthropathy

The neoplasia chapter describes the cause as unknown.

Association with lung carcinoma is established; A single causal mediator is not established in the supplied text.

The lecture should not assign an invented cytokine pathway as proven.

Pathogenesis and clinical recognition must be presented at different certainty levels.

Slide 54 · Case: Clubbing with periosteal changes

Vignette

A patient with a lung tumor develops digital clubbing, painful joints, and new periosteal bone at the distal long bones.

Interpretation

Recognize the full syndrome rather than clubbing alone.

Do not ascribe a proven mediator to the syndrome.

Answer

Hypertrophic pulmonary osteoarthropathy; The source does not establish its cause.

Illustrative teaching scenario — not a clinical case report

Slide 55 · Leukemoid reactions

Lung carcinoma can be associated with hematologic abnormalities, including leukemoid reactions.

A leukemoid pattern is a reactive systemic blood-picture abnormality rather than proof of leukemia.

Its presence belongs to the paraneoplastic differential when local explanations are inadequate.

The lung chapter does not prescribe a specific mechanism or subtype for this finding.

Slide 56 · Cancer-associated hypercoagulability

Thrombotic events are an important systemic manifestation of cancer.

Trousseau syndrome is a classic cancer-associated thrombophilic phenotype.

Lung carcinoma, along with pancreatic and other cancers, may be associated.

Deep venous thrombosis and thromboembolism may complicate the course.

Slide 57 · A paraneoplastic route to thrombosis

Malignancy

Tumor-derived procoagulant products

Coagulation system

Enhanced clot activation

Clinical outcome

Venous thrombosis / embolism

Schematic

Slide 58 · Trousseau syndrome: Interpretation

The syndrome classically encompasses migratory thrombophlebitis in cancer.

Tumor products—including mucins in some cancers—to clotting activation.

The lung chapter also highlights deep vein thrombosis and thromboembolism.

Absence of a large tumor burden does not exclude a systemic prothrombotic effect.

Slide 59 · Nonbacterial thrombotic endocarditis

Advanced malignancy may be accompanied by bland fibrinous valve vegetations.

These lesions are sterile and reflect a hypercoagulable state.

Left-sided cardiac valves are commonly involved description.

Vegetation-derived emboli may produce additional systemic complications.

Slide 60 · Different vascular effects of cancer

Venous thrombotic events

Deep venous thrombosis

Migratory thrombophlebitis

Potential thromboembolism

Valve-associated thrombotic events

Sterile fibrinous vegetations

Nonbacterial thrombotic endocarditis

Potential systemic embolism

Slide 61 · Case: Venous thrombosis and an occult tumor

Vignette

A patient experiences migratory episodes of thrombophlebitis and is later diagnosed with lung carcinoma.

Interpretation

Interpret the vascular finding as a possible systemic tumor effect.

Separate a procoagulant syndrome from anatomical venous compression.

Answer

Trousseau phenomenon is a recognized cancer-associated hypercoagulable syndrome.

Illustrative teaching scenario — not a clinical case report

Slide 62 · Organ-system classification at a glance

System

Examples in lung cancer

Typical mechanism

Endocrine

SIADH; Cushing; hypercalcemia

Ectopic tumor mediators

Neurologic

Lambert–Eaton; sensory neuropathy

Often immunologic

Skin / musculoskeletal

Acanthosis; osteoarthropathy

Variable / incompletely known

Vascular / blood

Trousseau; leukemoid reaction

Clotting and host responses

Slide 63 · Tumor-subtype associations worth remembering

Primary histology

High-yield association

Limitation

Small cell lung carcinoma

SIADH; ACTH syndrome; Lambert–Eaton

A tendency, not an exclusive rule

Squamous cell carcinoma

Humoral hypercalcemia

Often PTH-related protein

Pulmonary carcinoid

Carcinoid syndrome

Only a subset is functional

Slide 64 · A syndrome can reveal an occult lung tumor

Systemic manifestations can arise before a pulmonary mass is clinically detected.

The most informative clues combine a characteristic phenotype with a plausible tumor association.

Examples include Lambert–Eaton, ectopic ACTH syndrome, and inappropriate ADH secretion.

A compatible syndrome supports investigation; It does not by itself establish malignancy.

Slide 65 · Do not confuse paraneoplasia with metastasis

Metastatic effect

Distant tumor deposit causes local injury

Bone metastasis causes osteolytic hypercalcemia

Brain metastasis causes focal neurologic effects

Paraneoplastic effect

Systemic mediator or immune response

PTH-related humoral hypercalcemia

Lambert–Eaton without neural deposits

Slide 66 · A pathology-based diagnostic reasoning sequence

Recognize syndrome

Define endocrine / neural / vascular phenotype

Classify mechanism

Local, metastatic, humoral or immune?

Evaluate tumor

Identify pulmonary lesion and histologic subtype

Schematic

This is an instructional reasoning schematic, not a formal practice guideline.

Slide 67 · Avoid three diagnostic shortcuts

Do not infer small cell carcinoma solely because a patient has SIADH.

Do not assume hypercalcemia must reflect bone metastasis.

Do not label any clubbing as hypertrophic osteoarthropathy.

Use the clinical phenotype, underlying mechanism and confirmed tumor findings together.

Slide 68 · Integrated case: Three clues, three pathways

Vignette

A pulmonary cancer patient develops hyponatremia, episodic muscle weakness that improves after activity, and venous thrombosis.

Interpretation

Hyponatremia → ectopic ADH / SIADH.

Facilitating weakness → Lambert–Eaton.

Venous thrombosis → hypercoagulability.

Answer

One tumor may produce multiple distinct systemic manifestations; Do not force a single mediator to explain all three.

Illustrative teaching scenario — not a clinical case report

Slide 69 · Clinical consequences and prioritization

Electrolyte disturbances can be clinically significant even if the pulmonary mass is small.

Neuromuscular dysfunction may be functionally disabling before tumor detection.

Thromboembolism creates complications independent of thoracic invasion.

These are not incidental associations: They may alter the immediate clinical problem.

Slide 70 · Consolidation: Four pathologic principles

Ectopic products create remote hormonal phenotypes.

Autoimmunity can injure a neuromuscular target shared with a tumor.

Thrombotic and connective-tissue reactions broaden the phenotype beyond hormones.

Histologic associations aid pattern recognition but are never absolute.

Slide 71 · Rapid retrieval: Finding → mechanism

Finding

Most directly supported explanation

Hyponatremia with SIADH

Tumor-derived antidiuretic activity

Cushing syndrome

Ectopic ACTH / ACTH-like peptides

Hypercalcemia without bone destruction

PTH-related humoral substances

Facilitating limb weakness

Presynaptic calcium-channel autoantibodies

Clubbing + periostitis + arthritis

Hypertrophic pulmonary osteoarthropathy

Slide 72 · References and source boundaries

Primary: Robbins, Cotran & Kumar, Pathologic Basis of Disease, 11th ed. (2026), Chapter 15, pp. 653–659.

Mechanistic context: Chapter 7, pp. 294–295, including Table 7.11.

Neuromuscular detail: Chapter 27, pp. 1115–1116.

Diagnostic algorithms and therapeutic recommendations are outside this source-restricted lecture.